Comparative Risk of Recurrent Esophageal Variceal Hemorrhage and Other Decompensation Events with Carvedilol Versus Propranolol in Patients with Cirrhosis: A Retrospective Study
Compared to propranolol, the use of carvedilol in patients with history of cirrhosis and EVH was associated with lower risk of recurrent EVH, further decompensation episodes, undergoing LT, and mortality.
Authors
- Khalid Aloum (ORCID: https://orcid.org/0009-0004-2653-0891)
- Mostafa Najim (ORCID: https://orcid.org/0000-0003-1848-2346)
- Kamran Qureshi (ORCID: https://orcid.org/0000-0002-0389-7269)
- Shahem Abbarh (ORCID: https://orcid.org/0000-0001-6812-2192)
- Mohammad Kloub (ORCID: https://orcid.org/0000-0001-7115-7353)
- Mahmoud Y. Madi (ORCID: https://orcid.org/0000-0001-5759-3386)
- Abdellatif Ismail
- Wing‐Kin Syn
- Mohammed Abusuliman (ORCID: https://orcid.org/0009-0006-7672-2896)
- Mohammed Al-Aquily
Institutions
- Norwalk Hospital (US)
- University of the Basque Country (ES)
- New York Medical College (US)
- Henry Ford Hospital (US)
- Unity Health System (US)
- Cleveland Clinic Florida (US)
- Saint Michael's Medical Center (US)
- Unity Hospital (US)
- Saint Louis University (US)
- The University of Texas at Austin (US)
- MedStar Health (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Digestive Diseases and Sciences
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1007/s10620-025-09453-6
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Association for the Study of Liver Diseases